1-4 of 4
Naveed M. Chowhan, MD.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rapid Prospective Identification of Non-Germinal Center B Cell-Like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) Patients for Targeted Trials: Early Results From PYRAMID, A Phase 2 Randomized Study of R-CHOP ± Bortezomib In Newly Diagnosed Non-GCB DLBCL.

Kevin Doner, MD, Ian W. Flinn, MD, PhD, Brian K. Ulrich, MD, Stephen J. Noga, MD, PhD, Naveed M. Chowhan, MD, Steven W. Papish, MD, Tallat Mahmood, MD, James A Reeves, MD, Nicholas J. Di Bella, MD, Gerald J. Robbins, MD, Radhakrishnan Ramchandren, MD, Sein Aung, MD, William Lawler, MD, Sudha Parasuraman, MD, Maria M. Corvez, BA, George Mulligan, PhD, John P. Leonard, MD
Journal: Blood
Blood (2010) 116 (21): 1792.
https://doi.org/10.1182/blood.V116.21.1792.1792
Published: 2010
Journal Articles

Immune (Idiopathic) Thrombocytopenic Purpura (ITP): Treatment Pattern and Splenectomy Rate from a Multinational Prospective Observational Study

Francesco Rodeghiero, MD, Axel C. Matzdorff, MD, Tiziano Barbui, MD, Jean- Francois Viallard, MD, PhD, Naveed M. Chowhan, MD, Robert Robles, MD, Boriana Kamenova, MD, Ze Cong, MS, Robert Deuson, PhD, John J. Isitt, MS
Journal: Blood
Blood (2008) 112 (11): 4538.
https://doi.org/10.1182/blood.V112.11.4538.4538
Published: 2008
Journal Articles

Initial Results from an International Study in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma To Confirm the Activity, Safety and Criteria for Predicting Response to Lenalidomide Monotherapy.

Thomas E. Witzig, MD, Craig B. Reeder, MD, Jonathan Polikoff, MD, Naveed M. Chowhan, MD, Isaac Esseessee, MD, Richard Greenberg, MD, Hermant Patel, MD, Davood Vafai, MD, Peter H. Wiernik, MD, Annette Ervin-Haynes, DO, Dennis Pietronigro, PhD, Jerome B. Zeldis, MD, PhD, Myron Czuczman, MD
Journal: Blood
Blood (2007) 110 (11): 2572.
https://doi.org/10.1182/blood.V110.11.2572.2572
Published: 2007
Journal Articles

A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated Bulky Stage II or Stage III or IV, Low-Grade B-Cell NHL.

Raul R. Mena, MD, Neal P. Christiansen, MD, David W. Nyman, DO, Yudhishtra Markan, MD, Naveed M. Chowhan, MD.
Journal: Blood
Blood (2005) 106 (11): 4750.
https://doi.org/10.1182/blood.V106.11.4750.4750
Published: 2005